125 related articles for article (PubMed ID: 29439902)
21. Discovery of aryl-biphenyl-2-ylmethylpiperazines as novel scaffolds for 5-HT(7) ligands and role of the aromatic substituents in binding to the target receptor.
Kim Y; Kim J; Tae J; Roth BL; Rhim H; Keum G; Nam G; Choo H
Bioorg Med Chem; 2013 May; 21(9):2568-76. PubMed ID: 23541835
[TBL] [Abstract][Full Text] [Related]
22. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
[TBL] [Abstract][Full Text] [Related]
23. Privileged scaffold-based design to identify a novel drug-like 5-HT
Lacivita E; Niso M; Stama ML; Arzuaga A; Altamura C; Costa L; Desaphy JF; Ragozzino ME; Ciranna L; Leopoldo M
Eur J Med Chem; 2020 Aug; 199():112395. PubMed ID: 32442850
[TBL] [Abstract][Full Text] [Related]
24. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.
Cappelli A; Anzini M; Vomero S; Canullo L; Mennuni L; Makovec F; Doucet E; Hamon M; Menziani MC; De Benedetti PG; Bruni G; Romeo MR; Giorgi G; Donati A
J Med Chem; 1999 May; 42(9):1556-75. PubMed ID: 10229626
[TBL] [Abstract][Full Text] [Related]
25. Are the Hydantoin-1,3,5-triazine 5-HT
Lubelska A; Latacz G; Jastrzębska-Więsek M; Kotańska M; Kurczab R; Partyka A; Marć MA; Wilczyńska D; Doroz-Płonka A; Łażewska D; Wesołowska A; Kieć-Kononowicz K; Handzlik J
Molecules; 2019 Dec; 24(24):. PubMed ID: 31817628
[TBL] [Abstract][Full Text] [Related]
26. Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
Kołaczkowski M; Marcinkowska M; Bucki A; Śniecikowska J; Pawłowski M; Kazek G; Siwek A; Jastrzębska-Więsek M; Partyka A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P
Eur J Med Chem; 2015 Mar; 92():221-35. PubMed ID: 25557493
[TBL] [Abstract][Full Text] [Related]
27. Extended N-Arylsulfonylindoles as 5-HT₆ Receptor Antagonists: Design, Synthesis & Biological Evaluation.
Vera G; Lagos CF; Almendras S; Hebel D; Flores F; Valle-Corvalán G; Pessoa-Mahana CD; Mella-Raipán J; Montecinos R; Recabarren-Gajardo G
Molecules; 2016 Aug; 21(8):. PubMed ID: 27537868
[TBL] [Abstract][Full Text] [Related]
28. 1-Sulfonyl-6-Piperazinyl-7-Azaindoles as potent and pseudo-selective 5-HT6 receptor antagonists.
Fabritius CH; Pesonen U; Messinger J; Horvath R; Salo H; Gałęzowski M; Galek M; Stefańska K; Szeremeta-Spisak J; Olszak-Płachta M; Buda A; Adamczyk J; Król M; Prusis P; Sieprawska-Lupa M; Mikulski M; Kuokkanen K; Chapman H; Obuchowicz R; Korjamo T; Jalava N; Nowak M
Bioorg Med Chem Lett; 2016 Jun; 26(11):2610-5. PubMed ID: 27117428
[TBL] [Abstract][Full Text] [Related]
29. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B
Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR.
Intagliata S; Modica MN; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Romeo G
Bioorg Med Chem Lett; 2016 Aug; 26(16):4052-6. PubMed ID: 27396505
[TBL] [Abstract][Full Text] [Related]
31. Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134).
Bromidge SM; Clarke SE; Gager T; Griffith K; Jeffrey P; Jennings AJ; Joiner GF; King FD; Lovell PJ; Moss SF; Newman H; Riley G; Rogers D; Routledge C; Serafinowska H; Smith DR
Bioorg Med Chem Lett; 2001 Jan; 11(1):55-8. PubMed ID: 11140733
[TBL] [Abstract][Full Text] [Related]
32. Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists.
Bromidge SM; Clarke SE; King FD; Lovell PJ; Newman H; Riley G; Routledge C; Serafinowska HT; Smith DR; Thomas DR
Bioorg Med Chem Lett; 2002 May; 12(10):1357-60. PubMed ID: 11992776
[TBL] [Abstract][Full Text] [Related]
33. Some pharmacological properties of new analogs of MP 3022, the 5-HT1A receptor antagonist.
Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E; Paluchowska MH
Pol J Pharmacol; 1999; 51(5):405-13. PubMed ID: 10817541
[TBL] [Abstract][Full Text] [Related]
34. Optimization of (arylpiperazinylbutyl)oxindoles exhibiting selective 5-HT₇ receptor antagonist activity.
Volk B; Gacsályi I; Pallagi K; Poszávácz L; Gyönös I; Szabó E; Bakó T; Spedding M; Simig G; Szénási G
J Med Chem; 2011 Oct; 54(19):6657-69. PubMed ID: 21859099
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and structure-activity relationships of a new model of arylpiperazines. 1. 2-[[4-(o-methoxyphenyl)piperazin-1-yl]methyl]-1, 3-dioxoperhydroimidazo[1,5-alpha]pyridine: a selective 5-HT1A receptor agonist.
López-Rodríguez ML; Rosado ML; Benhamú B; Morcillo MJ; Sanz AM; Orensanz L; Beneitez ME; Fuentes JA; Manzanares J
J Med Chem; 1996 Oct; 39(22):4439-50. PubMed ID: 8893838
[TBL] [Abstract][Full Text] [Related]
36. 5-HT
Ates A; Burssens P; Lorthioir O; Lo Brutto P; Dehon G; Keyaerts J; Coloretti F; Lallemand B; Verbois V; Gillard M; Vermeiren C
ChemMedChem; 2018 Apr; 13(8):795-802. PubMed ID: 29451954
[TBL] [Abstract][Full Text] [Related]
37. HBK-7 - A new xanthone derivative and a 5-HT1A receptor antagonist with antidepressant-like properties.
Pytka K; Kazek G; Siwek A; Mordyl B; Głuch-Lutwin M; Rapacz A; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B; Zygmunt M
Pharmacol Biochem Behav; 2016; 146-147():35-43. PubMed ID: 27132236
[TBL] [Abstract][Full Text] [Related]
38. Pharmacophore Comparison and Development of Recently Discovered Long Chain Arylpiperazine and Sulfonamide Based 5-HT7 Ligands.
Rague A; Tidgewell K
Mini Rev Med Chem; 2018; 18(7):552-560. PubMed ID: 28901854
[TBL] [Abstract][Full Text] [Related]
39. Towards metabolically stable 5-HT7 receptor ligands: a study on 1-arylpiperazine derivatives and related isosters.
Lacivita E; De Giorgio P; Patarnello D; Niso M; Colabufo NA; Berardi F; Perrone R; Satala G; Duszynska B; Bojarski AJ; Leopoldo M
Exp Brain Res; 2013 Oct; 230(4):569-82. PubMed ID: 23571499
[TBL] [Abstract][Full Text] [Related]
40. Arylpiperazine derivatives of 3-propyl-beta-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor ligands.
Byrtus H; Pawłowski M; Duszyńska B; Wesołowska A; Chojnacka-Wójcik E; Bojarski AJ
Pol J Pharmacol; 2001; 53(4):395-401. PubMed ID: 11990087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
